| Megan E Cox, | |
|
750 E Thunderbird Rd Ste 1-3, Phoenix, AZ 85022 | |
| (602) 230-7373 | |
| (602) 218-6383 |
| Full Name | Megan E Cox |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 750 E Thunderbird Rd Ste 1-3, Phoenix, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013592229 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | LPC-22973 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Megan E Cox, 3101 N Central Ave Ste 550, Phoenix, AZ 85012-2635 Ph: (602) 230-7373 | Megan E Cox, 750 E Thunderbird Rd Ste 1-3, Phoenix, AZ 85022 Ph: (602) 230-7373 |
News Archive
Current HIV treatments do not eradicate HIV from host cells but rather inhibit virus replication and delay the onset of AIDS. However, a new research published in BioMed Central's open access journal, AIDS Research & Therapy describes an innovative approach to eliminate HIV in host by targeted killing of only HIV infected cells. This approach if successful could lead into an anti-HIV therapy that will eradicate the virus.
Specific impairments within six large-scale brain networks during drug cue exposure, decision-making, inhibitory control, and social-emotional processing are associated with drug addiction behaviors, according to a systematic review of more than 100 published neuroimaging studies by experts at the Icahn School of Medicine at Mount Sinai and published Wednesday, June 6 in the journal Neuron.
Antares Pharma, Inc. today announced that the first patient has been dosed in a clinical study evaluating the VIBEX™ MTX product which is being developed for the treatment of rheumatoid arthritis. The clinical study will evaluate several dose strengths of VIBEX MTX delivered with a proprietary autoinjector versus conventional needle and syringe administration by a healthcare professional.
Engineering researchers developed a next-generation miniature lab device that uses magnetic nano-beads to isolate minute bacterial particles that cause diseases.
The Stanford University School of Medicine and SanBio Inc. today announced the initiation of a Phase 1/2a clinical trial testing the safety and efficacy of a novel allogeneic cell therapy product, SB623, on patients suffering from stable deficits resulting from previous stroke injuries.
› Verified 3 days ago
Ms. Martha White, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3306 W Catalina Dr, Phoenix, AZ 85017 Phone: 602-353-0703 Fax: 602-353-0715 | |
Philip Lee Mcdonald, LMSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 1648 S 16th St, Phoenix, AZ 85034 Phone: 714-235-1970 | |
Melinda Chapin, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 3640 W Osborn Rd, Phoenix, AZ 85019 Phone: 602-269-5300 Fax: 602-269-5380 | |
Beverly Seyler, M.S. Counselor Medicare: Not Enrolled in Medicare Practice Location: 4525 E Saint Anne Ave, Phoenix, AZ 85042 Phone: 602-431-6685 | |
Mrs. Virginia Joyce Gatson, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1110 E Mcdowell Rd, Phoenix, AZ 85006 Phone: 602-685-1940 Fax: 602-685-1944 | |
Katherine Jackson, Counselor Medicare: Not Enrolled in Medicare Practice Location: 9920 W Camelback Rd Unit 2026, Phoenix, AZ 85037 Phone: 253-208-0756 | |
Margaret Ann Beresford, MC, ATR-BC, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 4545 N. 36th Street, Suite 117, Phoenix, AZ 85018 Phone: 602-509-5771 |